0
Letters   |    
Fractal and Statistical Features for the Discrimination Between Patients With Amyotrophic Lateral Sclerosis and Healthy Adults
Ali Falaki, Ph.D. Student; Farshad Almasganj, Ph.D.; Farzad Towhidkhah, Ph.D.
The Journal of Neuropsychiatry and Clinical Neurosciences 2013;25:E22-E22. 10.1176/appi.neuropsych.12010020
View Author and Article Information

Amirkabir University of Technology Biomedical Engineering Tehran Islamic Republic of Iran

Correspondence: ali_falaki@yahoo.com

Copyright © 2013 American Psychiatric Association

Extract

To the Editor: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder, by which 2 in 100,000 individuals are affected each year,1 that affects primary motor neurons in cerebral cortex, brain stem, and spinal cord.2 Degeneration of motor neurons will hinder sending cerebrum impulses to the muscle fibers, impairing voluntary movements. Muscle twitching and spasticity, difficulties in speech, swallowing, and breathing are most commonly known symptoms of ALS. One of the most salient features in determining disease severity and appropriate treatment is gait disorder in form of increase in mean stride interval and decrease in mean speed of walking.3 Stride-to-stride fluctuations in healthy adults show alteration in a chaotic manner; these have a fractal (self-similar) structure more than a random one,4,5 which would approach a stochastic state.5

Figures in this Article

First Page Preview

View Large
First page PDF preview
Your Session has timed out. Please sign back in to continue.
Sign In Your Session has timed out. Please sign back in to continue.
Sign In to Access Full Content
 
Username
Password
Sign in via Athens (What is this?)
Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
Not a subscriber?

Subscribe Now/Learn More

PsychiatryOnline subscription options offer access to the DSM-IV-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

+

References

Rothstein  JD:  Current hypotheses for the underlying biology of amyotrophic lateral sclerosis.  Ann Neurol   2009; 65(Suppl 1):S3–S9
[CrossRef] | [PubMed]
 
Brown  RH  Jr:  Amyotrophic lateral sclerosis. Insights from genetics.  Arch Neurol   1997; 54:1246–1250
[CrossRef] | [PubMed]
 
Hausdorff  JM;  Lertratanakul  A;  Cudkowicz  ME  et al.:  Dynamic markers of altered gait rhythm in amyotrophic lateral sclerosis.  J Appl Physiol   2000; 88:2045–2053
[PubMed]
 
Scafetta  N;  Marchi  D;  West  BJ:  Understanding the complexity of human gait dynamics.  Chaos   2009; 19:026108
[CrossRef] | [PubMed]
 
Hausdorff  JM:  Gait dynamics, fractals and falls: finding meaning in the stride-to-stride fluctuations of human walking.  Hum Mov Sci   2007; 26:555–589
[CrossRef] | [PubMed]
 
Wu  Y;  Shi  L:  Analysis of altered gait cycle duration in amyotrophic lateral sclerosis based on nonparametric probability density function estimation.  Med Eng Phys   2011; 33:347–355
[CrossRef] | [PubMed]
 
Dutta  S;  Chatterjee  A;  Munshi  S:  An automated hierarchical gait pattern identification tool employing cross-correlation-based feature extraction and recurrent neural network based classification.  Expert Syst   2009; 26:202–217
[CrossRef]
 
Liao  F;  Wang  J;  He  P:  Multi-resolution entropy analysis of gait symmetry in neurological degenerative diseases and amyotrophic lateral sclerosis.  Med Eng Phys   2008; 30:299–310
[CrossRef] | [PubMed]
 
References Container
+
+

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content
Books
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 1.  >
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 12.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 1.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 1.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 3.  >
Topic Collections
Psychiatric News
APA Guidelines